ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

HHA “Investigative Memorandum” Revives Controversy Over AIDS Virus, Royalties

July 1, 1994

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

March 30, 2012

Cancer Policy: New Cancer Board to Take A Year to Conduct First Study

April 18, 1997

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

In Brief: Rhoads Renamed Cancer Advisory Board Chairman; L-B’s Frederick Contract Renewed For $12 Million

June 28, 1974